China Care Atlas logo
China Care Atlas
  • Home
  • Hospitals
  • Treatments
  • Build My Plan
  • Guides
China Care Atlas logo
China Care Atlas

Compare top hospitals, advanced treatments, and transparent medical tourism information for China before you book travel.

Quick Links
HospitalsTreatmentsBuild My PlanGuides
Advanced Treatments
CAR-T & Cell TherapyProton & Heavy IonCardiovascular SurgeryComplex Neurosurgery
Legal
AboutContactHow We ResearchPrivacy PolicyTerms

2026 China Care Atlas. Advanced, Transparent Healthcare in China.

Hospital specialists reviewing a treatment plan in China
SPECIALTY & TREATMENT DIRECTORY

Specialties & Treatments in China

45Fudan specialty rankings loaded5Major Treatment Directions26Treatment pathways reviewedEditorial research desk · independent

Research-stage dataset · status research only · intake details needs direct confirmation · directions reviewed 18 August 2026. Not a clinical recommendation; confirm eligibility and access directly with the hospital.

Popular:
Research-stage hospital & therapy matrix

Advanced Treatment Pathways & Hospital Centers

Research notes on Chinese tertiary centers, advanced modalities (CAR-T, particle therapy, robotic surgery, organ transplant), target indications, and international patient access routes. Capability notes are starting points for direct confirmation, not a referral or acceptance decision.

Dataset status research only·intake release needs direct confirmation·reviewed 18 August 2026

Clinical Desk 04复杂神经疾病Research review · needs direct confirmation

Complex neurological diseases

National neurological centers offering robotic stereo-EEG, MR-guided laser ablation (LITT), deep brain stimulation (DBS), and microvascular bypass for complex brain disorders.

Explore Full Guide & Hospitals

Leading Hospital Centers & Specific Treatments Offered

Research notes on Chinese tertiary hospitals, specific advanced modalities, target indications, and international patient pathways

2 hospitals profiled
Directory cross-check0 of 4 candidates in our hospital directory4 not yet listed
  • Beijing Tiantan Hospitalnot in our hospital directory
  • Huashan Hospitalnot in our hospital directory
  • Shanghai Proton and Heavy Ion Centernot in our hospital directory
  • Ruijin Hospitalnot in our hospital directory

A missing entry means our hospital directory does not cover that facility yet; it is not a statement about the facility's clinical capability.

Beijing Tiantan Hospital (首都医科大学附属北京天坛医院)
BeijingGrade 3A Public · National Center for Neurological Disorders
Capability noted in research
Specific Advanced Treatments & Technologies Offered:
Advanced NeuromodulationLeading Center Technique
Robot-Assisted SEEG & MRgLITT Laser Thermal Ablation
Target Indication:

Drug-resistant focal epilepsy, hypothalamic hamartomas, deep periventricular heterotopias

Clinical Feature: Sub-millimeter electrode trajectory planning; scarless MR-guided laser probe ablation avoiding open craniotomy.

Advanced NeuromodulationNMPA Approved Commercial
Deep Brain Stimulation (DBS) with Directional Leads
Target Indication:

Parkinson's disease, generalized dystonia, severe essential tremor

Clinical Feature: Directional current steering avoiding capsular side effects; full-cycle wireless remote parameter tuning via 5G cloud.

International Patient Access:

International Medical Department provides English clinical liaison, remote imaging review, and dedicated private inpatient rooms.

Pre-Travel Candidacy Note:

Active intake for international neurosurgical cases. Requires high-resolution 3.0T MRI and long-term VEEG records.

Huashan Hospital, Fudan University (复旦大学附属华山医院)
ShanghaiGrade 3A Public · National Medical Center for Neurological Disorders
Capability noted in research
Specific Advanced Treatments & Technologies Offered:
Complex Surgery & TransplantGlobal Pioneer Benchmark
Combined Direct/Indirect STA-MCA Revascularization Bypass
Target Indication:

Moyamoya disease, atherosclerotic internal carotid occlusion with hemodynamic failure

Clinical Feature: Direct 1.0mm micro-anastomosis plus encephalo-duro-myo-synangiosis, restoring immediate cerebral blood flow.

Complex Surgery & TransplantNational Reference Center
Awake Brain Surgery with Intraoperative Functional Mapping
Target Indication:

Gliomas, cavernous malformations, and epileptogenic lesions in eloquent speech and motor cortex

Clinical Feature: Direct cortical and subcortical stimulation testing real-time speech and movement, maximizing tumor resection while preserving function.

International Patient Access:

Huashan International Medical Center operates a comprehensive bilingual clinic coordinating second opinions and VIP admissions.

Pre-Travel Candidacy Note:

Direct international case intake. Documented overseas patient cases for moyamoya and brain tumor surgeries.

Cross-Specialty Collaboration Route:
Primary: NeurosurgeryNeurologyRadiologyPathologyRehabilitation medicineCritical care medicine

Target Disease Indications & Qualified Hospital Finder (4)

Which Chinese tertiary hospitals are noted for the beds, ICU support, and technologies each condition typically needs

4 target conditions
High-Priority Target#01
Drug-Resistant Focal Epilepsy (药物难治性局灶性癫痫)

Target Stage & Goal: Frequent disabling focal seizures persisting despite ≥2 appropriately chosen and tolerated anti-seizure medication regimens.

Hospitals noted for treating this condition (confirm eligibility directly):
Beijing Tiantan Hospital (首都医科大学附属北京天坛医院)
Beijing · National Neurological Diseases Clinical Medical Center (World's Largest Neurosurgical Center)
Comprehensive Epilepsy Center / Functional Neurosurgery
Hospital Facilities & Qualified Conditions:

Robotic stereo-electroencephalography (SEEG) frameless surgical suite, continuous video-EEG monitoring units (40+ monitoring beds), intraoperative MRgLITT laser thermal ablation platform.

Specific Treatment & Technology Offered:

Robot-Assisted SEEG Epileptogenic Zone Localization + Magnetic Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT) Minimally Invasive Ablation.

Required Patient Eligibility Criteria:

Failure of ≥2 appropriate anti-seizure medications; disabling focal seizures; non-invasive evaluation (3.0T epilepsy-protocol MRI, PET-CT, VEEG) showing concordant epileptogenic region.

Huashan Hospital, Fudan University (复旦大学附属华山医院)
Shanghai · National Center for Neurological Disorders
Department of Neurosurgery / Functional Group
Hospital Facilities & Qualified Conditions:

World-renowned neurosurgical electrophysiology laboratory, awake craniotomy cortical mapping setup, fMRI and magnetoencephalography (MEG) core.

Specific Treatment & Technology Offered:

Awake Craniotomy with Intraoperative Direct Cortical Stimulation (DCS) & Functional Brain Zone-Sparing Resection.

Required Patient Eligibility Criteria:

Epileptogenic focus situated within or adjacent to eloquent language or sensorimotor cortex; patient cooperative for awake intraoperative cognitive testing.

High-Priority Target#02
Advanced Parkinson's Disease & Movement Disorders (中晚期帕金森病与肌张力障碍)

Target Stage & Goal: Idiopathic Parkinson's disease with motor fluctuations, disabling dyskinesias, or severe drug-refractory tremors.

Hospitals noted for treating this condition (confirm eligibility directly):
Beijing Tiantan Hospital & Huashan Hospital
Beijing / Shanghai · National Neurosurgery Benchmarks
Functional Neurosurgery Division / Movement Disorders MDT
Hospital Facilities & Qualified Conditions:

Dedicated movement disorder clinical units, multi-channel microelectrode recording (MER) subcortical neural trajectory mapping, high-field MRI stereotactic fusion software, wireless remote telemedicine programming platforms.

Specific Treatment & Technology Offered:

Deep Brain Stimulation (DBS 脑深部电刺激术 / 脑起搏器) targeting subthalamic nucleus (STN) or globus pallidus internus (GPi).

Required Patient Eligibility Criteria:

Idiopathic Parkinson's disease for ≥5 years; clear responsiveness to levodopa (UPDRS-III score improvement ≥30%); severe motor fluctuations or disabling drug-induced dyskinesia; absence of severe cognitive dementia (MMSE >24) or major psychiatric depression.

Specialized Indication#03
Moyamoya Disease & Intracranial Arterial Occlusion (烟雾病与颅内脑血管闭塞)

Target Stage & Goal: Progressive steno-occlusive disease of the terminal internal carotid arteries and circle of Willis causing recurrent TIAs, stroke, or cerebral hemorrhage.

Hospitals noted for treating this condition (confirm eligibility directly):
Huashan Hospital, Fudan University (复旦大学附属华山医院)
Shanghai · Global Authority in Cerebrovascular Bypass Surgery
Cerebrovascular Neurosurgery Division
Hospital Facilities & Qualified Conditions:

Global authority in intracranial revascularization surgery; high-magnification neurosurgical operating microscopes; intraoperative indocyanine green (ICG) infrared videoangiography; continuous intraoperative neuro-electrophysiological monitoring.

Specific Treatment & Technology Offered:

Direct Superficial Temporal Artery to Middle Cerebral Artery (STA-MCA) Microvascular Anastomosis + Encephalo-Duro-Arterio-Synangiosis (EDAS 复合脑血管搭桥术).

Required Patient Eligibility Criteria:

Digital Subtraction Angiography (DSA) confirmed Suzuki stage II-V moyamoya disease; documented cerebral hemodynamic impairment (CT/MRI perfusion); history of ischemic TIA, completed stroke, or hemorrhage; non-acute phase (>2-4 weeks post-infarction).

Beijing Tiantan Hospital (北京天坛医院)
Beijing · National Neurological Diseases Clinical Center
Department of Cerebrovascular Surgery
Hospital Facilities & Qualified Conditions:

Comprehensive cerebrovascular disease clinical center, quantitative intraoperative ultrasound flow probes (Charbel probes), specialized neuro-ICU.

Specific Treatment & Technology Offered:

Combined direct and indirect surgical bypass for adult and pediatric moyamoya patients.

Required Patient Eligibility Criteria:

Angiographically verified ischemic or hemorrhagic moyamoya disease; stable neurological status.

Specialized Indication#04
Complex Skull Base Meningiomas & Acoustic Neuromas (复杂颅底脑膜瘤与听神经瘤)

Target Stage & Goal: Large petroclival, sphenoid wing, or cerebellopontine angle tumors compressing the brainstem and cranial nerves.

Hospitals noted for treating this condition (confirm eligibility directly):
Beijing Tiantan Hospital & Huashan Hospital
Beijing / Shanghai · National Neurosurgery Benchmarks
Skull Base Neurosurgery Division
Hospital Facilities & Qualified Conditions:

State Key Laboratory of Neuro-oncology, cranial nerve electrophysiological monitoring consoles (monitoring CN VII, VIII, IX, X, XI, XII), high-definition neuro-endoscopic platforms.

Specific Treatment & Technology Offered:

Retrosigmoid / Transpetrosal Microsurgical Radical Resection with Facial & Cochlear Nerve Functional Preservation, and Transclival Endoscopic Resection.

Required Patient Eligibility Criteria:

Histologically confirmed or radiographically typical skull base mass with brainstem compression, cranial nerve impairment, or progressive tumor enlargement.

Records Needed Before Clinical Review (5)

  • ✓High-resolution 3.0T Brain MRI (3D T1-MPRAGE, T2, FLAIR, and DWI/SWI sequences in original DICOM format)
  • ✓Digital Subtraction Angiography (DSA) or CT/MR Perfusion (CTP/MRP) reports and DICOM discs for vascular cases
  • ✓Continuous Video-EEG (VEEG) recordings (at least 24-48 hours including recorded clinical seizures) for epilepsy cases
  • ✓Levodopa challenge test video and UPDRS-III scoring sheet (for Parkinson's / DBS inquiries)
  • ✓Detailed anti-seizure or neurological drug history: Generic names, dosages, blood concentrations, and adverse effects

Practical Pathway Financial Scope (4 stages)

Where expenses occur across the pathway · figures are published reference ranges
Stage 1: Specialized Pre-Surgical Workup & Brain Mapping (术前专病精准评估与脑功能定位)

Scope: Admission for high-density VEEG monitoring, functional MRI / DTI tractography, PET-CT metabolic scan, and multidisciplinary surgical conference.

Financial Notes: Takes 3-5 days; verifies surgical feasibility and determines optimal stereotactic coordinates.

Stage 2: Surgical Procedure & Implant Device (神经外科施术与高科技植入物)

Scope: Craniotomy or robotic stereotactic implantation, intraoperative microelectrode recording, electrophysiology monitoring, and neurostimulation devices (DBS pulse generator / leads).

Financial Notes: DBS hardware is a major component (rechargeable dual-channel DBS device approx. 200,000 - 280,000 RMB in China).

Published reference range · noted 2026-08-18 · confirm current price

Stage 3: Neuro-Intensive Care & Post-Operative Management (神经重症监护与术后调控)

Scope: Post-op neuro-ICU monitoring (typically 1-2 days), repeat CT/MRI lead placement verification, and suture removal.

Financial Notes: Monitors brain edema, intracranial hemorrhage prevention, and early seizure prophylaxis.

Stage 4: Initial Parameter Programming & Telemedicine Setup (首次开机程控与远程云调谐)

Scope: Postoperative Day 14-30 initial DBS device activation, symptom threshold testing, medication reduction plan, and remote cloud tuning setup.

Financial Notes: Patients can return home with remote cloud-based telemedicine programming support from Chinese specialists.

Published reference ranges noted 2026-08-18; they are not a quote. Confirm the current itemized price and payment terms directly with the hospital before budgeting or travel.

Budgeting & Cost Scope Notice:

Device choices (rechargeable vs non-rechargeable DBS battery, imported vs domestic electrodes) and the need for prolonged SEEG phase-II invasive monitoring can materially alter total costs.

Published intake contacts — confirm before use
needs direct confirmation

These numbers and addresses are published references captured 2026-08-18. They have not been reconfirmed for this case — call or email the hospital yourself to confirm the channel is still open, who answers, and what they need before you send records. Published intake references captured on the date shown. They were not re-confirmed by phone or email on this page, and individual hospitals can change or limit international patient channels.

Pre-Travel Clinical Intake Advisory

Procedure-specific foreign-patient acceptance, emergency exclusion, implant programming, rehabilitation duration, and local follow-up

Advanced Clinical Research

Priority Treatment Directions

Dedicated clinical desks for complex, refractory, and rare conditions in China.

Desk 01血液肿瘤与细胞治疗

Hematologic cancers & cell therapy

Blood cancers, transplantation, and indication-specific cell therapies.

Priority Pathways

Relapsed or refractory multiple myelomaRelapsed or refractory large B-cell lymphomaAcute lymphoblastic leukemia

Key Centers

  • Ruijin Hospitalnot in our hospital directory
  • Shanghai SinoUnited Hospitalnot in our hospital directory
Explore Research Desk
Desk 02复杂或复发肿瘤

Complex or recurrent cancers

Multidisciplinary options for recurrent, refractory, or technically difficult tumors.

Priority Pathways

Recurrent nasopharyngeal and complex head-and-neck cancersRefractory or recurrent brain tumorsAdvanced CLDN18.2-positive gastric or gastroesophageal junction cancer

Key Centers

  • Shanghai Proton and Heavy Ion Centernot in our hospital directory
  • Fudan University Shanghai Cancer Centernot in our hospital directory
Explore Research Desk
Desk 03儿童复杂与罕见病

Pediatric complex & rare diseases

Specialist children’s hospitals for oncology, congenital disease, and rare-disease review.

Priority Pathways

Pediatric leukemia, lymphoma, and solid tumorsComplex congenital heart diseaseGenetic, metabolic, and undiagnosed rare diseases

Key Centers

  • Shanghai Children's Medical Centernot in our hospital directory
  • Children's Hospital of Fudan Universitynot in our hospital directory
Explore Research Desk
Desk 04复杂神经疾病

Complex neurological diseases

Neurosurgery, epilepsy, movement disorders, and coordinated rehabilitation.

Priority Pathways

Complex brain tumorsCerebrovascular malformations and complex cerebrovascular diseaseDrug-resistant epilepsy

Key Centers

  • Beijing Tiantan Hospitalnot in our hospital directory
  • Huashan Hospitalnot in our hospital directory
Explore Research Desk
Desk 05复杂心血管疾病

Complex cardiovascular diseases

Aortic, structural, congenital, and inherited heart-disease programs.

Priority Pathways

Aortic dissection and complex aortic diseaseAdult complex congenital heart diseasePediatric complex congenital heart disease

Key Centers

  • Fuwai Hospitalnot in our hospital directory
  • Shanghai Children's Medical Centernot in our hospital directory
Explore Research Desk

How to use this directory

Rankings as a Starting Guide

Use rankings to shortlist top departments, then verify international access and care fit.

  1. 01

    Choose the specialty first

    Start with the department that treats your condition, not the best-known hospital name.

  2. 02

    Align department strengths with access

    Review specialized clinical teams, English medical services, and admission channels alongside hospital reputation.

  3. 03

    Prepare structured clinical documentation

    Compile standardized diagnostic summaries, scans, and clinical histories to facilitate direct hospital evaluation.

Continue with a specific case

Build Your Care Pathway

Organize medical records, confirm hospital fit, and plan next steps before traveling.

Build a personalized care plan

1. Confirm the department route

Check that the named department, not only the hospital, can review the condition you are researching.

2. Prepare a usable record set

Bring translated summaries, imaging, pathology, treatment history, and a concise clinical question.

3. Confirm access before travel

Ask the hospital about appointment timing, record submission, language support, payment, and follow-up needs.

Next step

Choose your next step

Explore accredited public hospitals with dedicated international patient departments, or generate an individualized travel plan.

Explore Top HospitalsBuild My Plan